ArticleCancer research and treatment2020

SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer.

Yoo-Kang Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.